WordNet

a substance that exerts some force or effect
a businessman who buys or sells for another in exchange for a commission (同)factor, broker
any agent or representative of a federal agency or bureau (同)federal agent
a representative who acts on behalf of other persons or organizations
an active and efficient cause; capable of producing a certain effect; "their research uncovered new disease agents"
how long something has existed; "it was replaced because of its age"
a time of life (usually defined in years) at which some particular qualification or power arises; "she was now of school age"; "tall for his eld" (同)eld
begin to seem older; get older; "The death of his wife caused him to age fast"
make older; "The death of his child aged him tremendously"

PrepTutorEJDIC

『代理人』;周旋人 / 働き(作用)を起こすもの;作用物,薬剤 / (政府機関,特にFBI,CIAなどの)部員,機関員
〈U〉(一般に)『年齢』,寿命;〈C〉(個々の)『年齢』,年 / 〈U〉成年(おとなとしての資格・権利を得る年齢;通例18または21歳) / 〈U〉『老齢』;《集合的に》老人たち / 〈U〉(人生の)『一時期』;〈C〉世代(generation) / 〈U〉〈C〉《しばしばA-》(歴史上の)『時代』 / 〈C〉《話》長い間 / 年をとる,ふける;〈物が〉古くなる / 〈年〉'を'とらせる;〈物〉'を'古びさせる

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. ST上昇型心筋梗塞の急性期マネージメントの概要 overview of the acute management of st elevation myocardial infarction
2. 心不全患者における非心臓手術の麻酔 anesthesia for noncardiac surgery in patients with heart failure
3. 前立腺癌の危険因子 risk factors for prostate cancer
4. 第二世代（非定型）抗精神病薬中毒 second generation atypical antipsychotic medication poisoning
5. 第一世代（定型）抗精神病剤中毒 first generation typical antipsychotic medication poisoning

GYY4137, a hydrogen sulfide‑releasing molecule, inhibits the inflammatory response by suppressing the activation of nuclear factor‑kappa B and mitogen‑activated protein kinases in Coxsackie virus B3‑infected rat cardiomyocytes.

Wu Z1, Peng H1, Du Q1, Lin W1, Liu Y1.
Molecular medicine reports.Mol Med Rep.2015 Mar;11(3):1837-44. doi: 10.3892/mmr.2014.2901. Epub 2014 Nov 7.
GYY4137 is a water‑soluble, small molecule hydrogen sulfide (H2S)‑release agent that possesses potent cardioprotective and anti‑inflammatory properties in experimental models. Coxsackie virus B3 (CVB3) infection commonly causes viral myocarditis, which mainly involves immune cell infiltration,
PMID 25377925

Brain natriuretic peptide is able to stimulate cardiac progenitor cell proliferation and differentiation in murine hearts after birth.

Bielmann C1, Rignault-Clerc S, Liaudet L, Li F, Kunieda T, Sogawa C, Zehnder T, Waeber B, Feihl F, Rosenblatt-Velin N.
Basic research in cardiology.Basic Res Cardiol.2015 Jan;110(1):455. doi: 10.1007/s00395-014-0455-4. Epub 2014 Dec 2.
Brain natriuretic peptide (BNP) contributes to heart formation during embryogenesis. After birth, despite a high number of studies aimed at understanding by which mechanism(s) BNP reduces myocardial ischemic injury in animal models, the actual role of this peptide in the heart remains elusive. In th
PMID 25449896

Azelnidipine and glucose tolerance: possible indications and treatment selection for hypertensive patients with metabolic disorders.

Shimada K1, Miyauchi K, Daida H.
Expert review of cardiovascular therapy.Expert Rev Cardiovasc Ther.2015 Jan;13(1):23-31. doi: 10.1586/14779072.2015.986464. Epub 2014 Dec 1.
Azelnidipine is a unique dihydropyridine calcium channel blocker with selectivity for L-type calcium channels that has been launched for the treatment of hypertension. Azelnidipine exhibits long-acting blood pressure-lowering effects without increasing heart rate. High blood pressure is associated w
PMID 25434474

Astragaloside Ⅳ Inhibits Doxorubicin-Induced Cardiomyocyte Apoptosis Mediated by Mitochondrial Apoptotic Pathway via Activating the PI3K/Akt Pathway

Jia Yuanyuan,Zuo Daiying,Li Zengqiang [他],Liu Hanmo,Dai Zhengning,Cai Jiayi,Pang Lili,Wu Yingliang
Chemical and Pharmaceutical Bulletin 62(1), 45-53, 2014
… Thus, AS-IV may hold promise as an efficient cardioprotective agent against DIC. …
NAID 130003381803

Tolvaptan Attenuates Left Ventricular Fibrosis After Acute Myocardial Infarction in Rats

Yamazaki Takanori,Nakamura Yasuhiro,Shiota Masayuki [他],Osada-Oka Mayuko,Fujiki Hiroyuki,Hanatani Akihisa,Shimada Kenei,Miura Katsuyuki,Yoshiyama Minoru,Iwao Hiroshi,Izumi Yasukatsu
Journal of Pharmacological Sciences, 58-66, 2013
… Tolvaptan, a non-peptide V2-receptor antagonist, is a newly developed diuretic agent. … In this study, we investigated whether tolvaptan has a cardioprotective effect in acute heart failure after myocardial infarction (MI). … Each agent was administered for 2 weeks, and blood pressure levels and infarct sizes were similar in all MI groups. …
NAID 130003362738

LIAO Pei-Hu,HUNG Li-Man,CHEN Yi-Hung,KUAN Yu-Hsiang,ZHANG Friedrich Bo-Yuan,LIN Ruey-Hseng,SHIH Hung-Che,TSAI Shen-Kou,HUANG Shiang-Suo
Circulation journal : official journal of the Japanese Circulation Society 75(2), 443-450, 2011-01-25
… The cardioprotective effects of luteolin, a flavonoid that exhibits antioxidant properties and is widely available in many fruits and vegetables, were examined in rats subjected to myocardial IR injury. …
NAID 10027427369